Administering Vaccines: Dose, Route, Site, and Needle Size
Vaccines
Diphtheria, Tetanus, Pertussis (DTaP, DT, Td) Haemophilus influenzae type b (Hib) Hepatitis A (HepA)
Dose
0.5 mL
Route
IM
Site
Vastus lateralis: for infants (& toddlers lacking adequate deltoid mass); Deltoid: for toddlers, children & adults Vastus lateralis: for infants (& toddlers lacking adequate deltoid mass); Deltoid: for toddlers & children Vastus lateralis: for infants (& toddlers lacking adequate deltoid mass); Deltoid: for toddlers, children & adults Vastus lateralis: for infants (& toddlers lacking adequate deltoid mass); Deltoid: for toddlers, children & adults Administer 0.25 mL dose into each nostril while patient is in an upright position Vastus lateralis: for infants (& toddlers lacking adequate deltoid mass); Deltoid: for toddlers, children & adults Anterolateral fat of thigh: for young children Posterolateral fat of upper arm: for children & adults Anterolateral fat of thigh: for young children Posterolateral fat of upper arm: for children & adults Vastus lateralis: for infants (& toddlers lacking adequate deltoid mass); Deltoid: for toddlers & children Deltoid Anterolateral fat of thigh: for young children Posterolateral fat of upper arm: for children & adults Vastus lateralis: for infants (& toddlers lacking adequate deltoid mass); Deltoid: for toddlers, children & adults Anterolateral fat of thigh: for infants & young children Posterolateral fat of upper arm: for children & adults Anterolateral fat of thigh: for young children Posterolateral fat of upper arm: for children & adults
Needle Size
22–25g, 1–2"
0.5 mL
<18 yrs.: 0.5 mL >19 yrs.: 1.0 mL <19 yrs.: 0.5 mL* >20 yrs.: 1.0 mL
IM
22–25g, 1–2"
IM IM
Intranasal spray
22–25g, 1–2"
Hepatitis B (HepB) Influenza, live attenuated (LAIV) Influenza, trivalent inactivated (TIV) Measles, mumps, rubella (MMR) Meningococcal (Men) Pneumococcal conjugate (PCV)
22–25g, 1–2"
0.5 mL
6-35 mos: 0.25 mL >3 yrs.: 0.5 mL
NA
IM
22–25g, 1–2"
0.5 mL
SC
23–25g, 5/8"
0.5 mL
SC
23–25g, 5/8" 22–25g, 1–2"
0.5 mL
IM
Pneumococcal polysaccharide (PPV)
IM 0.5 mL SC IM
22–25g, 1–2"
23–25g, 5/8"
22–25g, 1-2"
Polio, inactivated (IPV)
0.5 mL SC 23–25g, 5/8"
Varicella (Var)
0.5 mL
SC
23–25g, 5/8"
*Persons 11 through 15 years of age may be given Recombivax HB® (Merck) 1.0 mL (adult formulation) on a 2–dose schedule.
Combination Vaccines
DTaP+HepB+IPV (Pediarix™) DTaP+Hib (Trihibit™) Hib+HepB (Comvax™) HepA+HepB (Twinrix®) 0.5 mL IM Vastus lateralis: for infants (& toddlers lacking adequate deltoid mass); Deltoid: for toddlers & children 22–25g, 1–2"
>18 yrs.: 1.0 mL
IM
Deltoid
22–25g, 1–2"
Please note: Always refer to the package insert included with each biologic for complete vaccine administration information. The Advisory Committee on Immunization Practices (ACIP) statement for the particular vaccine should be reviewed as well.
www.immunize.org/catg.d/p3085.pdf • Item #P3085 (11/03)
Immunization Action Coalition • 1573 Selby Avenue • St. Paul, MN 55104 • (651) 647-9009 • www.immunize.org
Lynne Larson, www.biovisuals.com
Lynne Larson, www.biovisuals.com
Lynne Larson, www.biovisuals.com
Lynne Larson, www.biovisuals.com
Lynne Larson, www.biovisuals.com
CDCdocs 5/6/2008 |
24 |
0 |
0 |
legal
CDCdocs 5/6/2008 |
19 |
0 |
0 |
legal
CDCdocs 5/6/2008 |
52 |
1 |
0 |
legal
CDCdocs 5/6/2008 |
51 |
1 |
0 |
legal
CDCdocs 5/6/2008 |
15 |
0 |
0 |
legal
anonymous 5/5/2008 | 116 | 1 | 0 | business
anonymous 5/5/2008 | 95 | 0 | 0 | business
anonymous 5/5/2008 | 95 | 0 | 0 | business
anonymous 5/5/2008 | 82 | 0 | 0 | business
anonymous 5/5/2008 | 74 | 1 | 0 | business
shanti12 1/11/2008 |
699 |
117 |
1 |
EPADocs 5/13/2008 |
12 |
0 |
0 |
legal
CDCdocs 5/6/2008 |
139 |
1 |
0 |
legal
stevenchow 9/5/2008 |
71 |
0 |
0 |
legal
EIA 5/30/2008 |
17 |
1 |
0 |
legal
CDCdocs 5/8/2008 |
220 |
2 |
0 |
legal
CDCdocs 5/8/2008 |
280 |
3 |
0 |
legal
CDCdocs 5/8/2008 |
143 |
2 |
0 |
legal
CDCdocs 5/8/2008 |
202 |
3 |
0 |
legal
CDCdocs 5/8/2008 |
135 |
2 |
0 |
legal
CDCdocs 5/8/2008 |
236 |
2 |
1 |
legal
CDCdocs 5/8/2008 |
124 |
0 |
0 |
legal
CDCdocs 5/8/2008 |
164 |
0 |
0 |
legal
CDCdocs 5/8/2008 |
132 |
1 |
0 |
legal
CDCdocs 5/8/2008 |
132 |
0 |
0 |
legal